MedPath

Dextrose

5% Dextrose Injection, USP

Approved
Approval ID

bd250a46-d229-4e80-b5a1-b34169ccecc4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 24, 2022

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 013547657

Products 4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dextrose Monohydrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65219-236
Application NumberANDA207449
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dextrose Monohydrate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 24, 2022
FDA Product Classification

INGREDIENTS (1)

DEXTROSE MONOHYDRATEActive
Quantity: 5000 mg in 100 mL
Code: LX22YL083G
Classification: ACTIB

Dextrose Monohydrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65219-240
Application NumberANDA207449
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dextrose Monohydrate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 24, 2022
FDA Product Classification

INGREDIENTS (2)

DEXTROSE MONOHYDRATEActive
Quantity: 25000 mg in 500 mL
Code: LX22YL083G
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT

Dextrose Monohydrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65219-234
Application NumberANDA207449
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dextrose Monohydrate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 24, 2022
FDA Product Classification

INGREDIENTS (1)

DEXTROSE MONOHYDRATEActive
Quantity: 2500 mg in 50 mL
Code: LX22YL083G
Classification: ACTIB

Dextrose Monohydrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65219-238
Application NumberANDA207449
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dextrose Monohydrate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 24, 2022
FDA Product Classification

INGREDIENTS (2)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
DEXTROSE MONOHYDRATEActive
Quantity: 12500 mg in 250 mL
Code: LX22YL083G
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dextrose - FDA Drug Approval Details